They are: Contaminated or mislabelled compounded products research-grade vs pharmaceutical-grade manufacturing matters enormously Incorrect dosing without clinical oversight, patients routinely underdose (no effect) or overdose (unknown risk) Drug interactions particularly relevant if you are on GLP-1 therapy, immunosuppressants, or anti-inflammatory medications
Kim SY, Min DS, Choi J-S, Choi YS, Park H-J, Sung K-W, et al
Alias routine typically features a hydrating mist or serum infused with ingredients like hyaluronic acid, glycerin, or peptides
Appetite and food reward 3-arm Phase 1 tirzepatide vs liraglutide 3.0 mg vs placebo: measured lunch intake fell 524.6 kcal vs placebo by week 3 (about 72% by week 6), with craving and hedonic-hunger reductions exceeding liraglutide